Kathryn F. Mills

Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice

Jun Yoshino, Kathryn F. Mills, Myeong Jin Yoon et al. · Cell Metabolism · 2011 · 1.3K citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme

Javier R. Revollo, Antje Körner, Kathryn F. Mills et al. · Cell Metabolism · 2007 · 898 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice

Kathryn F. Mills, Shohei Yoshida, Liana R. Stein et al. · Cell Metabolism · 2016 · 896 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in Mice

Mitsukuni Yoshida, Akiko Satoh, Jonathan B. Lin et al. · Cell Metabolism · 2019 · 415 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women

Mihoko Yoshino, Jun Yoshino, Brandon D. Kayser et al. · Science · 2021 · 409 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +16